https://adalta-elementor.cclayers.com/investors/news-media-old/ 2023-10-23T10:47:28+00:00 https://adalta-elementor.cclayers.com/biotech-daily-adalta-ipo-raise-10m-ad-114-fibrosis/ 2016-08-22T10:28:57+00:00 https://adalta-elementor.cclayers.com/adalta-receives-vc-investment-from-perth-based-yuuwa-capital/ 2016-08-22T10:29:49+00:00 https://adalta-elementor.cclayers.com/significant-i-body-publication/ 2016-08-22T10:30:02+00:00 https://adalta-elementor.cclayers.com/adalta-expands-its-scientific-advisory-team/ 2016-08-22T10:30:06+00:00 https://adalta-elementor.cclayers.com/adalta-awarded-voucher-to-explore-benefits-of-technologies-with-ferring-research-institute/ 2016-08-22T10:30:09+00:00 https://adalta-elementor.cclayers.com/adalta-and-roche-sign-agreement-to-evaluate-shark-antibody-technology/ 2016-08-22T10:30:13+00:00 https://adalta-elementor.cclayers.com/us-patent-granted-for-adalta-i-body-technology/ 2016-08-22T10:30:16+00:00 https://adalta-elementor.cclayers.com/adalta-and-the-university-of-melbourne-to-develop-i-bodies-for-the-treatment-of-various-eye-diseases/ 2016-08-22T10:30:31+00:00 https://adalta-elementor.cclayers.com/japanese-patent-granted-for-adalta-i-body-technology/ 2016-08-22T10:30:38+00:00 https://adalta-elementor.cclayers.com/adalta-expands-its-scientific-advisory-team-2/ 2016-08-22T10:30:53+00:00 https://adalta-elementor.cclayers.com/lonza-and-adalta-announce-a-strain-development-contract-for-novel-biologic-therapeutics/ 2016-08-22T10:30:58+00:00 https://adalta-elementor.cclayers.com/adalta-collaborates-with-crossbeta-to-find-i-body-for-alzheimers-disease/ 2016-08-22T10:31:05+00:00 https://adalta-elementor.cclayers.com/adalta-and-baker-idi-sign-agreement-to-identify-i-bodies-to-anti-thrombotic-target/ 2016-08-22T10:31:14+00:00 https://adalta-elementor.cclayers.com/adalta-appoints-dr-paul-macleman-chairman/ 2016-08-24T02:52:39+00:00 https://adalta-elementor.cclayers.com/drug-discovery-company-adalta-raises-au10m-subscribed-australian-ipo-accelerate-new-therapies-lung-fibrosis/ 2016-08-24T03:03:26+00:00 https://adalta-elementor.cclayers.com/australian-drug-discovery-company-adalta-announces-ipo-accelerate-new-therapies-lung-fibrosis/ 2016-08-24T03:04:32+00:00 https://adalta-elementor.cclayers.com/test-post/ 2016-08-24T08:48:17+00:00 https://adalta-elementor.cclayers.com/test-post-2/ 2016-08-24T08:49:47+00:00 https://adalta-elementor.cclayers.com/appendix-1a/ 2016-08-24T08:51:13+00:00 https://adalta-elementor.cclayers.com/information-form-checklist/ 2016-08-24T08:54:42+00:00 https://adalta-elementor.cclayers.com/prospectus-dated-8-july-2016/ 2016-08-24T08:56:35+00:00 https://adalta-elementor.cclayers.com/top-twenty/ 2016-08-24T08:57:20+00:00 https://adalta-elementor.cclayers.com/distribution-schedule/ 2016-08-24T08:58:10+00:00 https://adalta-elementor.cclayers.com/constitution-adalta/ 2016-08-24T08:59:34+00:00 https://adalta-elementor.cclayers.com/employee-share-option-plan/ 2016-08-24T09:00:27+00:00 https://adalta-elementor.cclayers.com/corporate-governance-policies-committee-charters/ 2016-08-24T09:01:26+00:00 https://adalta-elementor.cclayers.com/financial-accounts-30-june-2013/ 2016-08-24T09:02:52+00:00 https://adalta-elementor.cclayers.com/financial-accounts-30-june-2014/ 2016-08-24T09:10:20+00:00 https://adalta-elementor.cclayers.com/financial-accounts-30-june-2015/ 2016-08-24T09:11:08+00:00 https://adalta-elementor.cclayers.com/financial-accounts-29-february-2016/ 2016-08-24T09:11:56+00:00 https://adalta-elementor.cclayers.com/initial-directors-interest-notice/ 2016-08-24T09:12:50+00:00 https://adalta-elementor.cclayers.com/initial-directors-interest-notice-2/ 2016-08-24T09:13:39+00:00 https://adalta-elementor.cclayers.com/initial-directors-interest-notice-3/ 2016-08-24T09:14:21+00:00 https://adalta-elementor.cclayers.com/initial-directors-interest-notice-4/ 2016-08-24T09:15:18+00:00 https://adalta-elementor.cclayers.com/initial-directors-interest-notice-5/ 2016-08-24T09:15:57+00:00 https://adalta-elementor.cclayers.com/adalta-ipo-accelerate-new-therapy-lung-fibrosis/ 2016-08-24T09:17:01+00:00 https://adalta-elementor.cclayers.com/investor-presentation/ 2016-08-24T09:21:44+00:00 https://adalta-elementor.cclayers.com/becoming-substantial-holder/ 2016-08-24T09:22:04+00:00 https://adalta-elementor.cclayers.com/becoming-substantial-holder-2/ 2016-08-24T09:31:36+00:00 https://adalta-elementor.cclayers.com/becoming-substantial-holder-3/ 2016-08-24T09:31:56+00:00 https://adalta-elementor.cclayers.com/becoming-substantial-holder-4/ 2016-08-24T09:34:57+00:00 https://adalta-elementor.cclayers.com/receipt-rd-tax-incentive/ 2016-08-30T01:41:52+00:00 https://adalta-elementor.cclayers.com/preliminary-final-report/ 2016-08-30T22:16:49+00:00 https://adalta-elementor.cclayers.com/receipt-innovation-connections-grant/ 2016-08-30T22:22:46+00:00 https://adalta-elementor.cclayers.com/biotech-meets-broker-presentation/ 2016-09-08T00:37:18+00:00 https://adalta-elementor.cclayers.com/adalta-receives-au0-73m-rd-tax-incentive/ 2016-09-12T11:46:05+00:00 https://adalta-elementor.cclayers.com/adalta-receives-australian-government-grant-advance-understanding-potential-new-lung-fibrosis-therapy/ 2016-09-12T11:48:28+00:00 https://adalta-elementor.cclayers.com/agreement-fujifilm-diosynth-biotechnologies/ 2016-09-12T11:50:16+00:00 https://adalta-elementor.cclayers.com/adalta-signs-agreement-fujifilm-diosynth-biotechnologies-begin-manufacturing-lead-fibrosis-drug-candidate/ 2016-09-12T11:52:24+00:00 https://adalta-elementor.cclayers.com/ndf-research-report/ 2016-09-13T22:35:08+00:00 https://adalta-elementor.cclayers.com/boishares-edition-662-26-august-2016/ 2016-09-13T22:36:42+00:00 https://adalta-elementor.cclayers.com/patersons-september-2016/ 2016-09-14T23:00:17+00:00 https://adalta-elementor.cclayers.com/drug-therapy-conferences-presentations/ 2016-09-16T00:35:24+00:00 https://adalta-elementor.cclayers.com/annual-report-shareholders/ 2016-09-19T04:43:14+00:00 https://adalta-elementor.cclayers.com/appendix-4g-corporate-governance-statement/ 2016-09-19T04:44:27+00:00 https://adalta-elementor.cclayers.com/adalta-present-two-new-drug-therapy-conferences-next-week/ 2016-09-19T04:45:36+00:00 https://adalta-elementor.cclayers.com/change-directors-interest-notice/ 2016-09-21T07:50:47+00:00 https://adalta-elementor.cclayers.com/appendix-3b/ 2016-09-26T23:14:05+00:00 https://adalta-elementor.cclayers.com/change-directors-interest-notice-2/ 2016-09-27T01:32:35+00:00 https://adalta-elementor.cclayers.com/change-directors-interest-notice-3/ 2016-09-27T01:32:59+00:00 https://adalta-elementor.cclayers.com/notice-annual-general-meeting-2016/ 2016-10-06T09:11:05+00:00 https://adalta-elementor.cclayers.com/update-orphan-drug-designation/ 2016-10-13T20:54:53+00:00 https://adalta-elementor.cclayers.com/adalta-present-forthcoming-industry-conferences/ 2016-10-19T03:07:45+00:00 https://adalta-elementor.cclayers.com/appendix-3b-2/ 2016-10-23T05:23:36+00:00 https://adalta-elementor.cclayers.com/change-directors-interest-notice-4/ 2016-10-23T05:25:26+00:00 https://adalta-elementor.cclayers.com/quarterly-review-appendix-4c/ 2016-10-26T21:54:33+00:00 https://adalta-elementor.cclayers.com/collaboration-agreement-xl-protein/ 2016-11-07T08:18:57+00:00 https://adalta-elementor.cclayers.com/collaboration-agreement-xl-protein-2/ 2016-11-07T20:16:57+00:00 https://adalta-elementor.cclayers.com/commercialisation-agreement-crossbeta-biosciences/ 2016-11-08T05:52:50+00:00 https://adalta-elementor.cclayers.com/commercialisation-agreement-crossbeta-biosciences-2/ 2016-11-08T05:56:07+00:00 https://adalta-elementor.cclayers.com/agm-presentation/ 2016-11-14T02:35:06+00:00 https://adalta-elementor.cclayers.com/results-of-agm/ 2016-11-14T05:40:45+00:00 https://adalta-elementor.cclayers.com/new-director/ 2016-11-14T22:02:20+00:00 https://adalta-elementor.cclayers.com/director-appointment/ 2016-11-14T22:06:28+00:00 https://adalta-elementor.cclayers.com/initial-directors-interest-notice-6/ 2016-11-14T23:00:00+00:00 https://adalta-elementor.cclayers.com/ndf-research-issues-research-adalta/ 2016-12-04T23:15:19+00:00 https://adalta-elementor.cclayers.com/positive-pre-clinical-data/ 2017-01-08T22:19:01+00:00 https://adalta-elementor.cclayers.com/adalta-announces-positive-pre-clinical-data-showing-lead-drug-candidate-broad-fibrosis-treatment-potential/ 2017-01-08T22:23:21+00:00 https://adalta-elementor.cclayers.com/updated-presentation-january-2017/ 2017-01-17T03:44:23+00:00 https://adalta-elementor.cclayers.com/adalta-receives-orphan-designation-ad-114/ 2017-01-18T00:46:08+00:00 https://adalta-elementor.cclayers.com/adalta-receives-orphan-designation-lead-drug-candidate-targeting-patients-idiopathic-pulmonary-disease/ 2017-01-18T00:46:22+00:00 https://adalta-elementor.cclayers.com/positive-results-adalta-bioshares-edition-680-january-2017/ 2017-01-24T01:52:42+00:00 https://adalta-elementor.cclayers.com/adalta-appendix-4c-quarterly/ 2017-01-30T22:17:26+00:00 https://adalta-elementor.cclayers.com/release-securities-escrow/ 2017-02-01T01:47:50+00:00 https://adalta-elementor.cclayers.com/half-yearly-report-accounts/ 2017-02-14T07:03:45+00:00 https://adalta-elementor.cclayers.com/bodies-continue-make-progress-ndf-research-february-2017/ 2017-02-20T01:16:13+00:00 https://adalta-elementor.cclayers.com/fibrosis-symposium-presentation-material/ 2017-02-22T22:35:32+00:00 https://adalta-elementor.cclayers.com/appendix-3b-3/ 2017-02-22T22:40:52+00:00 https://adalta-elementor.cclayers.com/adalta-held-inaugural-fibrosis-briefing/ 2017-03-20T01:51:50+00:00 https://adalta-elementor.cclayers.com/fibrosis-symposium-video-material/ 2017-03-20T22:02:45+00:00 https://adalta-elementor.cclayers.com/bioshares-edition-688-march-2017/ 2017-03-21T00:41:47+00:00 https://adalta-elementor.cclayers.com/adalta-expands-partnership-alfred-hospital/ 2017-03-21T06:45:34+00:00 https://adalta-elementor.cclayers.com/adalta-expands-collaboration-with-alfred-hospital/ 2017-03-21T06:47:39+00:00 https://adalta-elementor.cclayers.com/ticking-right-boxes-way-clinical-trials-patersons-march-2017/ 2017-03-31T00:35:18+00:00 https://adalta-elementor.cclayers.com/adalta-ceo-sam-cobb-present-stocks-watch-roadshows/ 2017-04-21T02:28:20+00:00 https://adalta-elementor.cclayers.com/adalta-releases-idiopathic-pulmonary-fibrosis-overview-document/ 2017-05-01T00:32:33+00:00 https://adalta-elementor.cclayers.com/fellowship-supports-search-new-disease-treatments/ 2017-07-24T00:05:52+00:00 https://adalta-elementor.cclayers.com/compelling-new-lung-disease-treatment-pioneered-victoria-gains-global-attention-alongside-top-researchers-drug-developers/ 2017-08-20T23:35:57+00:00 https://adalta-elementor.cclayers.com/ipf-profile-glen-westall/ 2017-08-31T05:27:34+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2017/08/DSC05182.jpg https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2017/ 2017-09-25T05:48:31+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2017/08/Bill-1.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2017/08/Max-1-2.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2017/08/MG_8825a-Anne-Holland_Physiotherapist.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2017/08/Stan-1.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2017/08/IMG_8978-copy.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2017/08/DSC05182.jpg https://adalta-elementor.cclayers.com/adalta-gets-commercial-ready-pre-clinical-safety-studies-show-promising-results/ 2017-11-22T02:32:34+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2017/11/AdAlta_AH0012-1.jpg https://adalta-elementor.cclayers.com/adalta-present-biotech-showcase-san-francisco/ 2018-01-09T00:54:40+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/01/AdAlta_AH0015.jpg https://adalta-elementor.cclayers.com/researcher-looks-next-generation-antibody-treatment-chronic-kidney-disease/ 2018-01-15T23:52:59+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/01/Carol-Pollock-1.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2018/01/Normal-Kidney-Biopsy.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2018/01/Diabetic-Nephropathy-Kidney-Biopsy.jpg https://adalta-elementor.cclayers.com/ceo-sam-cobb-speaks-health-invest-tv/ 2018-01-31T21:00:22+00:00 https://adalta-elementor.cclayers.com/ad-114-demonstrates-anti-fibrotic-effects-preclinical-models-lung-fibrosis/ 2018-03-19T04:55:48+00:00 https://adalta-elementor.cclayers.com/ceo-sam-cobb-speaks-health-radio-online/ 2018-04-17T22:50:59+00:00 https://adalta-elementor.cclayers.com/adalta-advance-improved-lung-fibrosis-therapy-ad-214/ 2018-04-23T01:16:58+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/04/AD-114-to-AD-214-image.jpg https://adalta-elementor.cclayers.com/commercial-potential-targeting-complex-proteins-gpcrs-ion-channels/ 2018-04-27T01:51:52+00:00 https://adalta-elementor.cclayers.com/adalta-seeking-head-drug-discovery/ 2018-05-22T22:56:32+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2016/04/new-slider2.jpg https://adalta-elementor.cclayers.com/adalta-shareholder-update-december-2017/ 2018-06-03T23:22:15+00:00 https://adalta-elementor.cclayers.com/adalta-shareholder-update-june-2018/ 2018-06-04T23:38:35+00:00 https://adalta-elementor.cclayers.com/ceo-sam-cobb-presents-gold-coast-investment-showcase/ 2018-06-25T05:46:17+00:00 https://adalta-elementor.cclayers.com/morgans-interview-sam-cobb/ 2018-06-27T06:05:14+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/01/AdAlta_AH0014.jpg https://adalta-elementor.cclayers.com/ceo-sam-cobb-presents-morgans-network/ 2018-06-27T06:10:03+00:00 https://adalta-elementor.cclayers.com/ceo-sam-cobb-profiled-fairfax-media-watch-csl-come/ 2018-06-27T06:53:01+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/06/AdAlta_AH0008.jpg https://adalta-elementor.cclayers.com/adalta-ipf-program-featured-small-caps/ 2018-06-27T07:07:24+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2017/08/IMG_8978-copy.jpg https://adalta-elementor.cclayers.com/adaltas-lead-program-ad-214-profiled-clinical-leader/ 2018-06-27T07:15:10+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2016/04/Slider2b.jpg https://adalta-elementor.cclayers.com/smaller-smarter-antibody-like-drugs-update-report-ndf-research/ 2018-07-06T02:08:07+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/07/NDF-10-Reasons-2.png http://adalta-elementor.cclayers.com/wp-content/uploads/2018/05/AD-114-to-AD-214-image.png https://adalta-elementor.cclayers.com/adalta-featured-abc-radio-national-roundtable-segment/ 2018-07-10T00:37:19+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/01/AdAlta_AH0015.jpg https://adalta-elementor.cclayers.com/ceo-sam-cobb-presents-morgans-network-2/ 2018-07-11T23:47:52+00:00 https://adalta-elementor.cclayers.com/wrap-adalta-ceo-sam-cobb-attends-121-tech-investment-hong-kong/ 2018-07-22T22:47:08+00:00 https://adalta-elementor.cclayers.com/adalta-announces-share-purchase-plan/ 2018-07-26T23:19:43+00:00 https://adalta-elementor.cclayers.com/adalta-conference-call-recording/ 2018-08-01T05:42:45+00:00 https://adalta-elementor.cclayers.com/australian-lung-fibrosis-patient-long-kayak-call-better-treatments/ 2018-08-02T04:37:54+00:00 https://adalta-elementor.cclayers.com/top-female-biotech-ceo-committed-readdressing-gender-imbalance-life-sciences/ 2018-08-02T06:58:19+00:00 https://adalta-elementor.cclayers.com/ceo-sam-cobb-provides-update-morgans-network/ 2018-08-14T01:33:41+00:00 https://adalta-elementor.cclayers.com/adaltas-body-platform-reaching-high-hanging-fruit/ 2018-08-14T06:00:52+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/07/low-hanging-fruit.png https://adalta-elementor.cclayers.com/adalta-named-finalist-australian-technologies-competition/ 2018-09-18T00:07:02+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/09/ATC-Finalist.png https://adalta-elementor.cclayers.com/pulmonary-fibrosis-awareness-month-2018/ 2018-09-20T00:07:04+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/09/Screen-Shot-2018-09-05-at-10.12.41-am.png http://adalta-elementor.cclayers.com/wp-content/uploads/2018/09/Screen-Shot-2018-09-05-at-2.02.33-pm.png http://adalta-elementor.cclayers.com/wp-content/uploads/2018/09/LKFL_Getting-ready.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2018/09/IMG_4407.jpeg https://adalta-elementor.cclayers.com/adalta-cso-mick-foley-speak-novel-drug-target-conference-usa/ 2018-09-25T23:25:39+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2017/08/IMG_8978-copy.jpg https://adalta-elementor.cclayers.com/ausbiotech-2018-adalta-ceo-sam-cobb-speak-leadership-diversity-gpcr-drug-target-panels/ 2018-10-22T22:21:51+00:00 https://adalta-elementor.cclayers.com/ceo-sam-cobb-presents-invetival-showcase-2018/ 2018-11-26T03:43:55+00:00 https://adalta-elementor.cclayers.com/ceo-sam-cobb-provides-update-morgans-network-2/ 2018-12-17T22:32:17+00:00 https://adalta-elementor.cclayers.com/shareholder-update-december-2018/ 2018-12-18T02:48:48+00:00 https://adalta-elementor.cclayers.com/ceo-provides-brief-update-proactive-investors/ 2019-01-20T21:34:34+00:00 https://adalta-elementor.cclayers.com/idiopathic-pulmonary-fibrosis-adaltas-body-approach/ 2019-02-03T21:54:01+00:00 https://adalta-elementor.cclayers.com/ceo-sam-cobb-present-february-investor-events/ 2019-02-13T23:27:06+00:00 https://adalta-elementor.cclayers.com/ceo-speaks-proactive-investors-body-technology-lead-program/ 2019-02-18T00:58:42+00:00 https://adalta-elementor.cclayers.com/pathway-clinic-special-investor-analyst-briefing-2019/ 2019-02-20T21:00:35+00:00 https://adalta-elementor.cclayers.com/ceo-sam-cobb-shares-leadership-experiences-stockhead/ 2019-02-25T00:38:21+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2018/06/AdAlta_AH0008.jpg https://adalta-elementor.cclayers.com/microscope-adalta-ceo-sam-cobb/ 2019-03-25T22:29:38+00:00 https://adalta-elementor.cclayers.com/rollercoaster-ride-biotech-ceo-sam-cobb-profiled-us-life-science-leader/ 2019-04-03T02:42:41+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2019/04/AdAlta_AH0021.jpg https://adalta-elementor.cclayers.com/ceo-sam-cobb-discussion-proactive-investors/ 2019-06-05T01:55:39+00:00 https://adalta-elementor.cclayers.com/ceo-sam-cobb-updates-morgans-network/ 2019-06-06T23:01:52+00:00 https://adalta-elementor.cclayers.com/shareholder-update-june-2019/ 2019-06-10T23:04:40+00:00 https://adalta-elementor.cclayers.com/ausbiotech-case-study-scarred-life/ 2019-06-24T23:44:22+00:00 https://adalta-elementor.cclayers.com/flurry-deals-demonstrates-significant-pharma-interest-ipf/ 2019-07-23T01:20:02+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2019/07/pharma-licensing.jpg https://adalta-elementor.cclayers.com/flexible-formatting-adaltas-body-technology/ 2019-09-03T23:32:46+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2019/06/i-body-half-life-variants.png https://adalta-elementor.cclayers.com/article-cso-mick-foley-next-generation-antibody-like-therapeutics-published-ebr/ 2020-04-06T02:08:42+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2020/04/MABs-cover.png http://adalta-elementor.cclayers.com/wp-content/uploads/2020/04/Antibodies-and-beyond.png https://adalta-elementor.cclayers.com/ceo-dr-tim-oldham-speaks-body-development-insights-care/ 2020-04-06T06:38:59+00:00 https://adalta-elementor.cclayers.com/ceo-dr-tim-oldham-interviewed-pitt-street-research/ 2020-05-08T04:52:16+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2020/05/Pitt-Street-video-pics-v2-002.png https://adalta-elementor.cclayers.com/ceo-update-investor-briefing-march-2020/ 2020-05-22T07:26:46+00:00 https://adalta-elementor.cclayers.com/video-ceo-dr-tim-oldham-talks-adalta-becoming-clinical-stage-company/ 2020-06-11T07:12:28+00:00 https://adalta-elementor.cclayers.com/moving-ad-214-clinic-adaltas-coming-age-moment/ 2020-07-06T05:20:01+00:00 https://adalta-elementor.cclayers.com/adalta-present-29-july-ird-invest/ 2020-07-22T03:50:35+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2020/07/AdAlta-Banner.png https://adalta-elementor.cclayers.com/ceo-tim-oldham-podcast-interview-australian-shareholders-association/ 2020-07-27T06:10:13+00:00 https://adalta-elementor.cclayers.com/looking-back-pulmonary-fibrosis-awareness-month-2020/ 2020-09-29T00:55:29+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2020/09/download.png https://adalta-elementor.cclayers.com/adalta-special-investor-briefing-2021/ 2021-03-31T03:50:39+00:00 https://adalta-elementor.cclayers.com/bioshares-adalta-prioritises-iv-formulation-for-ad-214/ 2022-12-22T07:54:47+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2022/12/delivery.jpg https://adalta-elementor.cclayers.com/adalta-rights-offer-webinar-recording-wednesday-3-may-2023/ 2023-05-04T07:05:45+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2023/05/Feature-Dr-Tim-Oldham.png https://adalta-elementor.cclayers.com/adalta-presents-at-twilight-investor-briefing/ 2023-05-30T00:31:41+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2023/05/Twilight-briefing-pic-1-e1685141391138.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2023/05/Twilight-briefing-pic-1-e1685141391138.jpg https://adalta-elementor.cclayers.com/adalta-presents-at-investor-summit/ 2023-06-14T06:33:20+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2023/06/Screenshot-Investor-Summit-1-June-2023.png https://adalta-elementor.cclayers.com/adalta-presents-at-tcn-emerging-asx-gems-conference/ 2023-07-13T02:23:35+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2023/07/AdAlta-Emerging-ASX-Gems-webinar-11-Nov-22.png https://adalta-elementor.cclayers.com/adalta-participates-in-us-emerging-growth-conference-13-july-2023/ 2023-07-14T08:27:55+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2023/07/Emerging-Growth-Conference-web-image.png https://adalta-elementor.cclayers.com/adalta-talks-to-bulls-n-bears-on-developments-for-fibrosis-sufferers/ 2023-07-20T01:48:37+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2023/07/Tim-in-lab-with-minister.jpg https://adalta-elementor.cclayers.com/adalta-investor-briefing-progress-of-ad-214-phase-i-extension-study/ 2023-08-16T03:22:10+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2023/08/AdAlta-webinar-thumbnail-10-Aug-2023.jpg https://adalta-elementor.cclayers.com/adalta-education-series-issue-one-fibrosis/ 2023-09-01T06:35:39+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2023/08/Fibrosis-website-blog-pic-e1693201200710.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2023/08/Fibrosis-website-blog-pic-e1693201200710.jpg http://adalta-elementor.cclayers.com/wp-content/uploads/2023/08/ibody-diagram-image.png https://adalta-elementor.cclayers.com/adalta-education-series-issue-two-september-is-pulmonary-fibrosis-awareness-month/ 2023-09-05T01:05:04+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2016/04/lungs.png http://adalta-elementor.cclayers.com/wp-content/uploads/2016/04/lungs.png https://adalta-elementor.cclayers.com/adalta-ceo-md-dr-tim-oldham-speaks-to-proactive-investors/ 2023-09-21T05:51:11+00:00 https://adalta-elementor.cclayers.com/adalta-ceo-and-md-dr-tim-oldham-appears-at-investor-summit/ 2023-09-22T05:59:45+00:00 https://adalta-elementor.cclayers.com/i-bodies-and-beyond-with-adaltas-tim-oldham-and-the-market-bull/ 2023-10-19T06:58:21+00:00 https://adalta-elementor.cclayers.com/adalta-education-series-issue-three-kidney-fibrosis/ 2023-10-23T10:47:28+00:00 http://adalta-elementor.cclayers.com/wp-content/uploads/2016/04/kidney.png